Matthew Greenwood
0000-0002-3667-2613
62 papers found
Refreshing results…
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A retrospective analysis from The Australasian Bone Marrow Transplant Recipient Registry
Adult B‐ and T‐lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes—a short report from two Sydney centres
Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement
Epstein‐Barr virus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation
Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival
Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens
A survey of infectious diseases and vaccination uptake in long‐term hematopoietic stem cell transplant survivors in Australia
Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in Australia
Expression of Intracellular Reactive Oxygen Species in Hematopoietic Stem Cells Correlates with Time to Neutrophil and Platelet Engraftment in Patients Undergoing Autologous Bone Marrow Transplantation
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse
Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts
Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia
Erratum to: “What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia” [Biol Blood Marrow Transplant 2016;22:731-743]
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study
Missing publications? Search for publications with a matching author name.